A Phase 1 Study to Assess Safety, Tolerability, and Pharmacokinetics of PUR3100, a Novel Dry Powder Formulation of Dihydroergotamine for Oral Inhalation, in Healthy Adults.

被引：0

作者：

Wasilewski, M. ^{[1
]}

Bodie, S. ^{[1
]}

Gonzalez, Nelson A. ^{[1
]}

Clayton, R. ^{[1
]}

Curran, A. ^{[1
]}

机构：

[1] Pulmatrix Inc, 99 Hayden Ave,Suite 390, Lexington, MA USA

来源：

HEADACHE | 2023年 / 63卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P-05

引用

页码：114 / 115

页数：2

共 50 条

[1] Safety, tolerability, and pharmacokinetics of a single orally inhaled dose of PUR3100, a dry powder formulation of dihydroergotamine versus intravenous dihydroergotamine: A Phase 1 randomized, double-blind study in healthy adults
Bodie, Susan
Curran, Aidan K.
Gonzalez-Nelson, Aaron C.
Perry, Jason M.
Manning, Debora C.
Wasilewski, Margaret M.
HEADACHE, 2024, 64 (06): : 643 - 651
[2] Phase 1 study of the safety and pharmacokinetics of staphylococcal protein a in healthy adults.
Haughey, David
Goldwater, Ronald
Leh, Anissa
Sloan, Victor S.
Jardieu, Paula
JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (09): : 1082 - 1082
[3] A phase 1/1b study of PUR1900, an inhaled formulation of itraconazole, in healthy volunteers and asthmatics to study safety, tolerability and pharmacokinetics
Hava, David L.
Tan, Lisa
Johnson, Patrick
Curran, Aidan K.
Perry, Jason
Kramer, Steve
Kane, Katie
Bedwell, Pauline
Layton, Gary
Swann, Clarie
Henderson, Dennis
Khan, Naimat
Connor, Lucy
McKenzie, Litza
Singh, Dave
Roach, James
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 86 (04) : 723 - 733
[4] First-in-Human Phase 1 Study To Assess Safety, Tolerability, and Pharmacokinetics of a Novel Antifungal Drug, VL-2397, in Healthy Adults
Mammen, Mammen P.
Armas, Danielle
Hughes, Frank H.
Hopkins, Andrew M.
Fisher, Cindy L.
Resch, Pamela A.
Rusalov, Denis
Sullivan, Sean M.
Smith, Larry R.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (11)
[5] A phase 1, ascending dose study to assess the potential effects of trofinetide on QTc interval, safety and tolerability, and pharmacokinetics in healthy adults
Darwish, M.
Harlick, J.
Youakim, J.
DeKarske, D.
Stankovic, S.
ANNALS OF NEUROLOGY, 2022, 92 : S174 - S174
[6] A Phase 1 Single and Multiple Ascending Dose (SAD/MAD) Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of AV-101, a Novel Inhaled Dry Powder Formulation of Imatinib in Healthy Subjects
Gillies, H.
Niven, R.
Dake, B.
Chakinala, M. M.
Feldman, J. P.
Hill, N. S.
Hoeper, M.
Humbert, M. J.
Mclaughlin, V. V.
Kankam, M.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
[7] Phase 1 Study To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Oral Doses of DS-2969b, a Novel GyrB Inhibitor, in Healthy Subjects
Vandell, Alexander G.
Inoue, Satoshi
Dennie, Justin
Nagasawa, Yasuo
Gajee, Roohi
Pav, Joe
Zhang, George
Zamora, Cynthia
Masuda, Nobuhisa
Senaldi, Giorgio
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (05)
[8] Pharmacokinetics, safety, and tolerability of the isatoribine oral prodrug ANA975 in a phase 1 healthy volunteer study
Kerr, B
Bauman, L
Webber, S
Xiang, A
Ng, J
Kirkovsky, L
Bartkowski, D
Steffy, K
Fletcher, S
Aust, R
Theiss, J
Averett, D
HEPATOLOGY, 2005, 42 (04) : 533A - 533A
[9] Effect of Food on the Pharmacokinetics, Safety, and Tolerability of Budesonide Oral Suspension in Healthy Adult Participants: A Randomized Phase 1 Study
Prokopienko, Alexander J.
Wang, Junyao
Yajnik, Vijay
Baratta, Mike
Desai, Nirav K.
Richmond, Camilla A.
Suri, Ajit
JOURNAL OF CLINICAL PHARMACOLOGY, 2025, 65 (02): : 217 - 225
[10] A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of DS-3801b, a Motilin Receptor Agonist, in Healthy Subjects
Dennie, Justin
Atiee, George
Warren, Vance
Tao, Ben
Morimoto, Kiyoshi
Senaldi, Giorgio
JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (09): : 1221 - 1230

← 1 2 3 4 5 →